Osborne Partners Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.3M | Sell |
119,356
-5,136
| -4% | -$458K | 0.69% | 46 |
|
|
2026
Q1 | $8.94M | Buy |
124,492
+4,633
| +4% | +$357K | 0.47% | 72 |
|
|
2025
Q4 | $9.51M | Sell |
119,859
-2,638
| -2% | -$208K | 0.49% | 69 |
|
|
2025
Q3 | $9.24M | Buy |
122,497
+1,842
| +2% | +$126K | 0.47% | 73 |
|
|
2025
Q2 | $8.32M | Sell |
120,655
-74,699
| -38% | -$4.9M | 0.44% | 81 |
|
|
2025
Q1 | $13.2M | Sell |
195,354
-11,452
| -6% | -$685K | 0.76% | 42 |
|
|
2024
Q4 | $9.28M | Sell |
206,806
-2,319
| -1% | -$130K | 0.54% | 69 |
|
|
2024
Q3 | $13.1M | Sell |
209,125
-1,872
| -0.9% | -$109K | 0.75% | 44 |
|
|
2024
Q2 | $12.5M | Buy |
210,997
+51,504
| +32% | +$3.22M | 0.75% | 42 |
|
|
2024
Q1 | $12.7M | Buy |
159,493
+5,855
| +4% | +$447K | 0.78% | 38 |
|
|
2023
Q4 | $12.1M | Buy |
153,638
+4,436
| +3% | +$316K | 0.79% | 39 |
|
|
2023
Q3 | $10.4M | Buy |
149,202
+2,939
| +2% | +$208K | 0.77% | 46 |
|
|
2023
Q2 | $10.1M | Buy |
146,263
+6,833
| +5% | +$486K | 0.73% | 48 |
|
|
2023
Q1 | $10.4M | Buy |
139,430
+3,703
| +3% | +$311K | 0.76% | 45 |
|
|
2022
Q4 | $12.6M | Buy |
135,727
+2,344
| +2% | +$226K | 0.99% | 29 |
|
|
2022
Q3 | $12.7M | Buy |
133,383
+47
| +0% | +$4.65K | 1.06% | 25 |
|
|
2022
Q2 | $12.4M | Sell |
133,336
-3,114
| -2% | -$304K | 0.95% | 31 |
|
|
2022
Q1 | $13.8M | Buy |
136,450
+1,238
| +0.9% | +$130K | 1.02% | 28 |
|
|
2021
Q4 | $13.9M | Buy |
135,212
+2,783
| +2% | +$257K | 1.02% | 29 |
|
|
2021
Q3 | $11.2M | Buy |
132,429
+8,072
| +6% | +$676K | 0.9% | 36 |
|
|
2021
Q2 | $10.4M | Buy |
124,357
+2,102
| +2% | +$172K | 0.85% | 38 |
|
|
2021
Q1 | $9.2M | Buy |
122,255
+5,577
| +5% | +$406K | 0.84% | 39 |
|
|
2020
Q4 | $7.97M | Sell |
116,678
-4,416
| -4% | -$287K | 0.97% | 30 |
|
|
2020
Q3 | $7.07M | Buy |
121,094
+4,109
| +4% | +$256K | 1.42% | 19 |
|
|
2020
Q2 | $7.6M | Sell |
116,985
-1,958
| -2% | -$123K | 1.63% | 17 |
|
|
2020
Q1 | $7.06M | Buy |
118,943
+312
| +0.3% | +$20.8K | 1.84% | 12 |
|
|
2019
Q4 | $8.81M | Sell |
118,631
-7,458
| -6% | -$524K | 1.78% | 12 |
|
|
2019
Q3 | $7.95M | Sell |
126,089
-854
| -0.7% | -$50.6K | 1.6% | 15 |
|
|
2019
Q2 | $6.92M | Buy |
126,943
+3,436
| +3% | +$185K | 1.32% | 21 |
|
|
2019
Q1 | $6.66M | Buy |
123,507
+4,506
| +4% | +$278K | 1.3% | 26 |
|
|
2018
Q4 | $7.8M | Buy |
119,001
+563
| +0.5% | +$42K | 1.17% | 26 |
|
|
2018
Q3 | $9.32M | Sell |
118,438
-869
| -0.7% | -$62.1K | 1.19% | 27 |
|
|
2018
Q2 | $7.68M | Buy |
119,307
+26,789
| +29% | +$1.77M | 1.05% | 31 |
|
|
2018
Q1 | $5.76M | Buy |
92,518
+419
| +0.5% | +$30.1K | 0.79% | 49 |
|
|
2017
Q4 | $6.68M | Sell |
92,099
-22,930
| -20% | -$1.67M | 0.88% | 41 |
|
|
2017
Q3 | $9.35M | Sell |
115,029
-5,114
| -4% | -$405K | 1.28% | 20 |
|
|
2017
Q2 | $9.67M | Buy |
120,143
+1,351
| +1% | +$107K | 1.38% | 18 |
|
|
2017
Q1 | $9.32M | Sell |
118,792
-15,675
| -12% | -$1.25M | 1.34% | 18 |
|
|
2016
Q4 | $10.6M | Sell |
134,467
-3,085
| -2% | -$250K | 1.55% | 14 |
|
|
2016
Q3 | $12.2M | Sell |
137,552
-722
| -0.5% | -$68.2K | 1.83% | 12 |
|
|
2016
Q2 | $13.2M | Sell |
138,274
-4,794
| -3% | -$478K | 1.97% | 12 |
|
|
2016
Q1 | $14.8M | Sell |
143,068
-148
| -0.1% | -$14.4K | 2.18% | 11 |
|
|
2015
Q4 | $14M | Buy |
143,216
+5,177
| +4% | +$507K | 2.04% | 12 |
|
|
2015
Q3 | $13.3M | Sell |
138,039
-610
| -0.4% | -$64.1K | 1.96% | 12 |
|
|
2015
Q2 | $14.5M | Buy |
138,649
+299
| +0.2% | +$30.5K | 1.95% | 13 |
|
|
2015
Q1 | $14.3M | Sell |
138,350
-23,975
| -15% | -$2.43M | 1.88% | 12 |
|
|
2014
Q4 | $15.6M | Buy |
162,325
+2,675
| +2% | +$236K | 1.89% | 13 |
|
|
2014
Q3 | $12.7M | Sell |
159,650
-3,754
| -2% | -$296K | 1.64% | 20 |
|
|
2014
Q2 | $12.3M | Buy |
163,404
+2,358
| +1% | +$178K | 1.58% | 20 |
|
|
2014
Q1 | $12.1M | Buy |
161,046
+2,026
| +1% | +$143K | 1.58% | 19 |
|
|
2013
Q4 | $11.4M | Buy |
159,020
+5,287
| +3% | +$340K | 1.48% | 20 |
|
|
2013
Q3 | $8.72M | Sell |
153,733
-1,390
| -0.9% | -$82.8K | 1.22% | 33 |
|
|
2013
Q2 | $8.87M | Buy |
+155,123
| New | +$8.99M | 1.27% | 28 |
|
Other funds holding CVS
Osborne Partners Capital Management's CVS Position: Q2 2026 in Review
Osborne Partners Capital Management reduced its CVS Health (CVS) stake by 4.1% in Q2 2026, selling an estimated $458K and leaving 119,356 shares worth $12.3M. The position accounts for 0.69% of the portfolio, ranked #46.
Osborne Partners Capital Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.6M in Q4 2014. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Osborne Partners Capital Management held 119,356 shares of CVS Health worth $12.3M as of Q2 2026.
- Osborne Partners Capital Management sold 5,136 CVS Health shares in Q2 2026, an estimated $458K.
- CVS Health made up 0.69% of Osborne Partners Capital Management's portfolio in Q2 2026, its #46 holding.
- Osborne Partners Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Osborne Partners Capital Management's CVS Health position peaked at $15.6M in Q4 2014.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Osborne Partners Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.